Page last updated: 2024-08-25

zoledronic acid and Non-alcoholic Fatty Liver Disease

zoledronic acid has been researched along with Non-alcoholic Fatty Liver Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jia, W; Jiang, S; Li, C; Qiu, Y; Shen, D; Tang, Q; Xue, B; Zhao, Y1
Ezzat, SF; Hamam, GG; Mohamed, RH; Tarek, M1
Anastasilakis, AD; Arsos, G; Kita, M; Kountouras, J; Litsas, I; Moralidis, E; Polyzos, SA; Terpos, E1

Other Studies

3 other study(ies) available for zoledronic acid and Non-alcoholic Fatty Liver Disease

ArticleYear
Zoledronic acid, an FPPS inhibitor, ameliorates liver steatosis through inhibiting hepatic de novo lipogenesis.
    European journal of pharmacology, 2017, Nov-05, Volume: 814

    Topics: Animals; Diphosphonates; Enzyme Activation; Geranyltranstransferase; Humans; Imidazoles; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; rhoA GTP-Binding Protein; Zoledronic Acid

2017
Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis.
    European journal of pharmacology, 2019, Sep-05, Volume: 858

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Glucose; Cytoprotection; Diet, High-Fat; Fasting; Liver; Male; Mevalonic Acid; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Triglycerides; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Zoledronic Acid

2019
Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:1

    Topics: Bone Density Conservation Agents; Chemical and Drug Induced Liver Injury; Diphosphonates; Fatty Liver; Female; Follow-Up Studies; Humans; Imidazoles; Middle Aged; Non-alcoholic Fatty Liver Disease; Osteitis Deformans; Radionuclide Imaging; Zoledronic Acid

2011